Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

163
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
163
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

653
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
653
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

212
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
212
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver Transplantation in the Era of Artificial Intelligence: Surgical Innovation, Risk Stratification, and Patient-centred Care.

Prague medical report·2026
Same author

Correction: Peram et al. Phospholipid-Based Ultraflexible Nanovesicular Gel of Sertaconazole Nitrate for the Treatment of Skin Fungal Infections: Statistical Optimization, In Vitro and Preclinical Assessment. <i>Gels</i> 2025, <i>11</i>, 909.

Gels (Basel, Switzerland)·2026
Same author

Melnick-Needles Syndrome: Synthesizing Current Knowledge on Etiology, Clinical Presentation, Diagnostic Methods, and Potential Therapeutic Options.

Prague medical report·2026
Same author

Phospholipid-Based Ultraflexible Nanovesicular Gel of Sertaconazole Nitrate for the Treatment of Skin Fungal Infections: Statistical Optimization, In Vitro and Preclinical Assessment.

Gels (Basel, Switzerland)·2025
Same author

Integrating a Pharmacovigilance and Response Unit Team for a Better Adverse Drug Reaction Reporting and Management: Insights from a Prospective Cross-Sectional Study.

Turkish journal of pharmaceutical sciences·2025
Same author

Novel Genotoxic Impurities in the First-Line Oral Anticoagulant Drug, Apixaban: Computational Toxicological Evaluation and Development of a Highly Sensitive LC-MS/MS Quantification Method.

Biomedical chromatography : BMC·2025

Related Experiment Video

Updated: Jan 8, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.5K

Signal detection in pharmacovigilance: Methods, tools, and workflows from case identification to adverse drug

Vinodkumar Mugada1, Vidyadhara Suryadevara2, Manasa Cheekurumilli3

  • 1Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Vignan Institute of Pharmaceutical Technology, Duvvada, AP, India.

Przeglad Epidemiologiczny
|December 12, 2025
PubMed
Summary

Adverse drug reactions (ADRs) are a major global health issue. Improving pharmacovigilance systems and prevention strategies, especially in low-resource settings, is crucial to reduce medication-related harm.

Keywords:
adverse drug reactionscomputer assisted signal detectionmedication errorspatient safetypharmacovigilance

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.1K
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

13.0K

Related Experiment Videos

Last Updated: Jan 8, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.5K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.1K
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

13.0K

Area of Science:

  • Pharmacovigilance and Public Health
  • Drug Safety and Epidemiology
  • Global Health Policy

Background:

  • Adverse drug reactions (ADRs) pose a significant, preventable global health burden, impacting morbidity, mortality, and healthcare costs.
  • Vulnerability to ADRs is high in older adults, low-resource settings, and with specific drug classes like antibiotics and cardiovascular agents.
  • Existing pharmacovigilance systems face challenges including underreporting, data quality issues, and methodological biases, particularly in low- and middle-income countries.

Purpose of the Study:

  • To synthesize global evidence on the burden, surveillance systems, and prevention strategies for ADRs.
  • To compare the strengths of various pharmacovigilance platforms and emerging analytical methods.
  • To identify policy priorities for reducing severe medication-related harm globally.

Main Methods:

  • Systematic review and synthesis of evidence from diverse global regions, healthcare settings, and drug classes.
  • Comparative analysis of pharmacovigilance platforms (e.g., WHO's VigiBase, EudraVigilance) and statistical methods (e.g., machine learning).
  • Evaluation of prescriber-level, system-level, and patient engagement prevention strategies.

Main Results:

  • Significant variability in ADR incidence and mortality exists globally, with specific populations and medications at higher risk.
  • Integrating spontaneous reporting with electronic health record analytics and employing advanced statistical methods like machine learning enhances ADR signal detection.
  • Active surveillance and digital tools show promise over voluntary reporting, but implementation is hindered by infrastructure and policy gaps.

Conclusions:

  • Achieving global goals for reducing medication-related harm requires integrating ADR surveillance into universal health coverage.
  • Policy interventions, including interoperable safety systems and capacity building in resource-limited settings, are essential.
  • Coordinated global action is needed to strengthen pharmacovigilance, enhance patient safety, and build sustainable health systems.